POSTER: ABCL-500 Longer Follow-Up Reaffirms Subcutaneous Epcoritamab Induces Deep and Durable Complete Remissions in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Updated Results From the Pivotal EPCORE NHL-1 Trial

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2023-09, Vol.23, p.S203-S203
Main Authors: Karimi, Yasmin, Ghesquieres, Herve, Jurczak, Wojciech, Cheah, Chan Y., Clausen, Michael Roost, Lugtenburg, Pieternella, Cunningham, David, Do, Young Rok, Lewis, David John, Gasiorowski, Robin, Kim, Tae Min, van der Poel, Marjolein, Poon, Michelle Limei, Feldman, Tatyana, Linton, Kim M., Sureda, Anna, Hutchings, Martin, Stirner, Mariana Cota, Liu, Yan, Kilavuz, Nurgul, Sacchi, Mariana, Thieblemont, Catherine
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(23)00718-8